PharmaMar signs a new agreement with Onko to commercialize Yondelis® in Turkey
(WorldNews Belgium)

PharmaMar signs a new agreement with Onko to commercialize Yondelis® in Turkey PharmaMar will receive an upfront payment and is eligible for additional remunerations, including regulatory milestone payments. Madrid, August 10th, 2020. - PharmaMar (MSE:PHM) has announced today a licensing agreement with Onko Ilac San ve Tic A.S. to commercialize the marine- derived anticancer drug Yondelis® (trabectedin) in Turkey. Under the terms of the agreement, PharmaMar will receive a non-disclosed upfront payment and will be eligible for additional remunerations, including regulatory milestone payments. PharmaMar will retain exclusive production rights of the product and will sell the product to Onko...